Innovative Recognition Chameleon Biosciences has received significant industry recognition by winning the Immunomodulatory Solution of the Year award, positioning it as a leader in developing safer gene therapy solutions.
Strong Industry Focus As a biotech startup specializing in immunomodulatory approaches for genetic disorders, the company presents opportunities for partnerships and collaborations in cutting-edge gene therapy and immune modulation.
Key Leadership The addition of experienced scientist and entrepreneur Thomas W. Chalberg to the board underscores the company's commitment to scientific excellence and potential for strategic growth partnerships.
Growth Potential With a modest revenue range and recent accolades, Chameleon Biosciences shows potential for future expansion, making it an attractive partner for investors and organizations seeking innovative biotech solutions.
Funding & Development While current revenue is under 1 million dollars, the company's focus on groundbreaking gene therapy technologies suggests significant future commercial opportunities once scaled and funded further.
Chameleon Biosciences, Inc. uses 8 technology products and services including RSS, Cloudflare, Google Cloud, and more. Explore Chameleon Biosciences, Inc.'s tech stack below.
| Chameleon Biosciences, Inc. Email Formats | Percentage |
| FirstL@chameleonbiosci.com | 100% |
Biotechnology ResearchCalifornia, United States2-10 Employees
Chameleon Biosciences, Inc. is a gene therapy startup company based out of Berkeley, CA, United States. Treatments for genetic disorders hold a lot of promise but won't be effective if they trigger an immune response from the very patient it's meant to help. We're working on a solution.
Company Overview
Media & News
Funding & FinancialsChameleon Biosciences, Inc.'s revenue is estimated to be in the range of $1M
Funding & FinancialsChameleon Biosciences, Inc.'s revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com